Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

HISTORICAL FACTS: Looking into plx pharma s return on capital employed | History Defined

Pulled from Benzinga Pro data, PLx Pharma (NASDAQ:PLXP) posted Q4 earnings of $3.56 million, an increase from Q3 of 116.46%. Sales dropped to $1.59 million, a 75.94% decrease between quarters. In Q3, PLx Pharma brought in $6.62 million in sales but lost $21.64 million in earnings.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.